AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 65 filers reported holding AKCEA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $180,000 | -96.9% | 10,600 | -97.2% | 0.00% | -96.8% |
| Q3 2019 | $5,749,000 | -69.5% | 373,500 | -53.5% | 0.06% | +24.0% |
| Q2 2019 | $18,840,000 | +65.6% | 803,400 | +100.0% | 0.05% | -26.5% |
| Q1 2019 | $11,380,000 | +76.1% | 401,700 | +87.4% | 0.07% | +61.9% |
| Q4 2018 | $6,462,000 | -13.9% | 214,400 | 0.0% | 0.04% | 0.0% |
| Q3 2018 | $7,508,000 | – | 214,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 3,162,643 | $53,575,000 | 0.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,723 | $536,000 | 0.19% |
| Amia Capital LLP | 28,217 | $478,000 | 0.14% |
| Motley Fool Asset Management LLC | 60,489 | $1,025,000 | 0.11% |
| Virtus ETF Advisers LLC | 33,059 | $560,000 | 0.09% |
| ALTRINSIC GLOBAL ADVISORS LLC | 70,286 | $1,191,000 | 0.05% |
| A.R.T. Advisors, LLC | 53,560 | $907,000 | 0.04% |
| TUDOR INVESTMENT CORP ET AL | 46,433 | $787,000 | 0.04% |
| Caption Management, LLC | 54,000 | $915,000 | 0.03% |
| Caption Management, LLC | 54,000 | $915,000 | 0.03% |